|
|
||||||||
2-adrenergic receptors
Baker Medical Research Institute and Alfred Heart Centre, Alfred Hospital, Melbourne 8008, Victoria, Australia
Effects
of cardiac specific overexpression of
2-adrenergic
receptors (
2-AR) on the development of heart failure
(HF) were studied in wild-type (WT) and transgenic (TG) mice following
myocardial infarction (MI) by coronary artery occlusion. Animals were
studied by echocardiography at weeks 7 to 8 and
by catheterization at week 9 after surgery. Post-infarct
mortality, due to HF or cardiac rupture, was not different among WT
mice, and there was no difference in infarct size (IS). Compared with
the sham-operated group (all P < 0.01), WT mice with
moderate (<36%) and large (>36%) IS developed lung congestion,
cardiac hypertrophy, left ventricular (LV) dilatation, elevated LV
end-diastolic pressure (LVEDP), and suppressed maximal rate of increase
of LV pressure (LV dP/dtmax) and fractional
shortening (FS). Whereas changes in organ weights and echo parameters
were similar to those in infarcted WT groups, TG mice had significantly higher levels of LV contractility in both moderate
(dP/dtmax 4,862 ± 133 vs. 3,694 ± 191 mmHg/s) and large IS groups (dP/dtmax
4,556 ± 252 vs. 3,145 ± 312 mmHg/s, both P < 0.01). Incidence of pleural effusion (36% vs. 85%,
P < 0.05) and LVEDP levels (6 ± 0.3 vs. 9 ± 0.8 mmHg, P < 0.05) were also lower in TG than in
WT mice with large IS. Thus
2-AR overexpression
preserved LV contractility following MI without adverse consequence.
echocardiography; heart failure; hemodynamics; transgenic mice
This article has been cited by other articles:
![]() |
L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du, X.-M. Gao, H. Kiriazis, X.-L. Moore, Z. Ming, Y. Su, A. M. Finch, R. A. Hannan, A. M. Dart, and R. M. Graham Transgenic {alpha}1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival Cardiovasc Res, September 1, 2006; 71(4): 735 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Barki-Harrington, C. Perrino, and H. A Rockman Network integration of the adrenergic system in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 391 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Dobson, J. Fray, J. L. Leonard, and R. E. Pratt Molecular mechanisms of reduced {beta}-adrenergic signaling in the aged heart as revealed by genomic profiling Physiol Genomics, October 17, 2003; 15(2): 142 - 147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |